| Lupin's specialised division that focuses on the Cardiac market continued to post strong results growing at 20% in FY 2010 commanding a 5.2% share of the overall Indian Cardiac market. The division also launched a neutraceutical in the year, Harty (Resveratrol). Five new brands were launched during FY 2010.
Key Products : Pinnacle CVS
|
Product |
Therapeutic Segment |
Product Rank In the relevant segment |
|
Clopitab
|
CVS |
1 |
|
Tonact
|
CVS |
2 |
|
Ramistar
|
CVS |
2 |
|
Lupenox
|
CVS |
2 |
|
Nebistar
|
CVS |
2 |
| 
